The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sjöberg, A. P.
Right arrow Articles by Blom, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sjöberg, A. P.
Right arrow Articles by Blom, A. M.
The Journal of Immunology, 2006, 176: 7612-7620.
Copyright © 2006 by The American Association of Immunologists

Regulation of Complement Activation by C-Reactive Protein: Targeting of the Inhibitory Activity of C4b-Binding Protein1

Andreas P. Sjöberg*, Leendert A. Trouw*, Fabian D. G. McGrath{dagger}, C. Erik Hack{dagger},{ddagger} and Anna M. Blom2,*

* Department of Laboratory Medicine, Section of Clinical Chemistry, Wallenberg Laboratory, University Hospital Malmö, Lund University, Malmö, Sweden; {dagger} Sanquin Research at the CLB and Laboratory for Experimental and Clinical Immunology, Academic Medical Center, Amsterdam, The Netherlands; and {ddagger} Department of Clinical Chemistry, Vrije Universiteit Medical Center, Amsterdam, The Netherlands

C-reactive protein (CRP) is the major acute phase protein in humans. It has been shown that CRP interacts with factor H, an inhibitor of the alternative pathway of complement, and now we demonstrate binding of CRP to the fluid-phase inhibitor of the classical pathway, C4b-binding protein (C4BP). C4BP bound to directly immobilized recombinant CRP as well as CRP attached to phosphorylcholine. The binding was sensitive to ionic strength and was enhanced in the presence of calcium. C4BP lacking beta-chain and protein S, which is a form of C4BP increasing upon inflammation, bound CRP with higher affinity than the C4BP-protein S complex. The binding could not be blocked with mAbs directed against peripheral parts of the {alpha}-chains of C4BP while the isolated central core of C4BP obtained by partial proteolytic digestion bound CRP, indicating that the binding site for CRP is localized in the central core of the C4BP molecule. Furthermore, we found complexes in serum from a patient with an elevated CRP level and trace amounts of CRP were also identified in a plasma-derived C4BP preparation. We were also able to detect C4BP-CRP complexes in solution and established that C4BP retains full complement regulatory activity in the presence of CRP. In addition, we found that C4BP can compete with C1q for binding to immobilized CRP and that it inhibits complement activation locally. We hypothesize that CRP limits excessive complement activation on targets via its interactions with both factor H and C4BP.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. E. Happonen, A. P. Sjoberg, M. Morgelin, D. Heinegard, and A. M. Blom
Complement Inhibitor C4b-Binding Protein Interacts Directly with Small Glycoproteins of the Extracellular Matrix
J. Immunol., February 1, 2009; 182(3): 1518 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A M Blom, K S Nandakumar, and R Holmdahl
C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice
Ann Rheum Dis, January 1, 2009; 68(1): 136 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Trouw, A. A. Bengtsson, K. A. Gelderman, B. Dahlback, G. Sturfelt, and A. M. Blom
C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack
J. Biol. Chem., September 28, 2007; 282(39): 28540 - 28548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Sjoberg, L. A. Trouw, S. J. Clark, J. Sjolander, D. Heinegard, R. B. Sim, A. J. Day, and A. M. Blom
The Factor H Variant Associated with Age-related Macular Degeneration (His-384) and the Non-disease-associated Form Bind Differentially to C-reactive Protein, Fibromodulin, DNA, and Necrotic Cells
J. Biol. Chem., April 13, 2007; 282(15): 10894 - 10900.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.